Andrew John Partridge - EVP & Chief Commercial Officer at Turning Point Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & Chief Commercial Officer
Stock Symbol
TPTX
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew John Partridge since 8/26/2023

Holdings reported by Andrew John Partridge for Turning Point Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 38.4K $2.92M $76.00 Feb 9, 2022 Direct
Stock Option (right to buy) 58.6K Feb 9, 2022 Direct Common Stock

Transactions reported by Andrew John Partridge for Turning Point Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.